WHO Technical Report Series 914. Geneva: World Health Organization; 2003. The selection and use of essential medicines. Report of WHO expert committee, 2002(including the 12th Model List of Essential Medicines).
Malhotra S. Essential medicines for noncommunicable diseases: “quality variable”. Int J Non-Commun Dis 2019;4(4):101–103. DOI: 10.4103/2468-8827.274464
Hajjou M, Krech L, Lane-Barlow C, et al. Monitoring the quality of medicines: results from Africa, Asia, and South America. Am J Trop Med Hyg 2015;92(6 Suppl):68–74. DOI: 10.4269/ajtmh.14-0535
Fadeyi I, Lalani M, Mailk N, et al. Quality of the antibiotics – amoxicillin and co-trimoxazole from Ghana, Nigeria, and the United Kingdom. Am J Trop Med Hyg 2015;92(6 Suppl):87–94. DOI: 10.4269/ajtmh.14-0539
Kondel R, Pandey AK, Arora A, et al. A pilot study to assess for mislabelling of drug samples with regards to amount of active ingredient. Int J Pharm Res Sch 2014;3(2):449–452.
Lalani M, Kaur H, Mohammed N, et al. Substandard antimalarials available in Afghanistan: a case for assessing the quality of drugs in resource poor settings. Am J Trop Med Hyg 2015;92(6 Suppl):51–58. DOI: 10.4269/ajtmh.14-0394
Bate R, Tren R, Mooney L, et al. Pilot study of essential drug quality in two major cities in India. PLoS One 2009;4(6):e6003. DOI: 10.1371/journal.pone.0006003
Nayyar GML, Breman JG, Herrington JE. The global pandemic of falsified medicines: laboratory and field innovations and policy perspectives. Am J Trop Med Hyg 2015;92(6 Suppl):2–7. DOI: 10.4269/ajtmh.15-0221
